US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,251.24

+78.536.70%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,271.88

Open:1,269.01

Low:1,233.67

Close:1,172.71

Loading ...

Amgen (AMGN) Gets a Buy from Piper Sandler

How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock

Asia Morning Call-Global Markets

3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Japan's Nikkei notches best week in 3 months on trade deal hopes

Market Chatter: Eli Lilly Releases Obesity Drug Zepbound in Japan

MT Newswires Live

Chugai Highlights Eli Lilly’s Promising Phase 3 Results for Orforglipron

Short Week Finishes with Netflix Q1 Beat

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Asia Morning Call-Global Markets

Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025

Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention

Simply Wall St.

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live

Early notable gainers among liquid option names on April 17th

Eli Lilly rises 13.0%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1251.235,"timestamp":1744919999999,"preClose":1172.706,"halted":0,"volume":114722595,"delay":0,"changeRate":0.066964,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":78.528931,"latestTime":"04-17 16:00:00 EDT","open":1269.007,"high":1271.8849,"low":1233.672,"amount":13696618708.83754,"amplitude":0.032585,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745242200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.286466,"peRate":32.45662,"turnoverRate":0.010861,"increases":5,"decrements":2,"flats":0,"marketCap":1333057296128,"floatMarketCap":1257599023328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1271.8849,"amplitude":0.032585,"preClose":1172.706,"low":1233.672,"pbRate":"9.286466","latestPrice":1251.235,"volume":114722595,"delay":0,"open":1269.007,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1150.8268,"twentyDayClose":1370.1545,"sixtyDayClose":1272.8855,"secType":"PLATE","market":"US","turnoverRate":0.010861,"peRate":32.45662,"marketCap":1333057296128,"floatMarketCap":1257599023328,"timestamp":1744919999999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529874629","title":"Amgen (AMGN) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874629?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:57","pubTimestamp":1745233039,"startTime":"0","endTime":"0","summary":"In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen (AMGN – Research Report), with a price target of $32...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/amgen-amgn-gets-a-buy-from-piper-sandler-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/amgen-amgn-gets-a-buy-from-piper-sandler-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","LU0122379950.USD","AMGN","LU0868494617.USD","BK4566","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4588","BK4533","LU2112291526.USD","LU2242652126.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU1571399168.USD","BK4599","IE0009355771.USD","BK4581","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1061106388.HKD","BK4534","SG9999001440.SGD","LU1983299246.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1023059063.AUD","LU2242646821.SGD","LU2089984988.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2529814537","title":"How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2529814537","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529814537?lang=en_us&edition=fundamental","pubTime":"2025-04-21 10:00","pubTimestamp":1745200859,"startTime":"0","endTime":"0","summary":"Pfizer  discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S. and internationally.It will report its Q1 2025 earnings on April 29. Wall Street analysts expect the company to post EPS of $0.70, down from $0.82 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $14.27 billion, down from $14.88 billion a year earlier.The 52-week range of Pfizer stock price was $20.92 to $31.54.Pfizer's dividend yield is 7.66%. It paid $1.72 per share in dividends during the last 12 months.Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!Can you guess how many retire with a $5,000,000 nest egg?How Can You Earn $100 Per Month As A Pfizer Investor?In summary, income-focused investors may find Pfizer stock an attractive option for making a steady income of $100 per month by owning 698 shares of stock. T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/put-100-retirement-fund-month-020059807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1023059063.AUD","BK4581","US3Y.BOND","BK4568","LU1066053197.SGD","LU0306807586.USD","LU1894683264.USD","SG9999002232.USD","US12M.BOND","US6M.BOND","BK4007","US7Y.BOND","IE00B19Z3581.USD","LU1894683348.USD","BK4533","LU0058720904.USD","SG9999001176.USD","LU1057294990.SGD","SG9999003800.SGD","BK4599","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0985481810.HKD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0122379950.USD","SGXZ57979304.SGD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","LU0225284248.USD","LU1066051498.USD","US2Y.BOND","LU0225771236.USD","US10Y.BOND","SG9999002224.SGD","BK4550","IE0002270589.USD","BK4588","LU0289739699.SGD","US30Y.BOND","BK4592","LU0234572021.USD","PFE","US5Y.BOND","LU0170899867.USD","IRR","LU0321505868.SGD","LU0868494617.USD"],"gpt_icon":1},{"id":"2529362899","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529362899?lang=en_us&edition=fundamental","pubTime":"2025-04-21 04:46","pubTimestamp":1745182002,"startTime":"0","endTime":"0","summary":"UPDATE 1-Asia Morning Call-Global MarketsApril 21 (Reuters) - Stock Marketsclosing level)Net ChngStock MarketsNet ChngS&P/ASX 200**7,819.1060.20NZX 50**12,118.9951.07DJIA39,142.23-527.16NIKKEI**34730.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250420:nL3N3PG1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1868836757.USD","LU2602419157.SGD","BK4599","IE00B1BXHZ80.USD","LU2211815571.USD","LU2237443895.HKD","LU2361044865.SGD","LU2471134796.USD","LU2237443549.SGD","SG9999015945.SGD","LU0256863902.USD","LU2491049909.HKD","LU1868836591.USD","BK4516","LU0354030511.USD","IE00B4R5TH58.HKD","SG9999014914.USD","LU0203202063.USD","IE00BK4W5M84.HKD","LU0354030438.USD","LU0471298777.SGD","LU1291159041.SGD","LU1061106388.HKD","LU1989771016.USD","SG9999013999.USD","LU1267930730.SGD","LU1551013425.SGD","LU0320765059.SGD","LU2237443382.USD","LU2360106947.USD","LU2491050154.USD","LU1720051108.HKD","LU0109391861.USD","SG9999001176.SGD","LU0114720955.EUR","LU0882574055.USD","GIC","LU1551013342.USD","LU0198837287.USD","LU2324357040.USD","IE00BJLML261.HKD","BK4581","LU0672654240.SGD","LU1093756325.SGD","SG9999014898.SGD","SG9999015978.USD","BK4007","LU2237443622.USD"],"gpt_icon":1},{"id":"2528310857","title":"3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap","url":"https://stock-news.laohu8.com/highlight/detail?id=2528310857","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528310857?lang=en_us&edition=fundamental","pubTime":"2025-04-20 17:45","pubTimestamp":1745142300,"startTime":"0","endTime":"0","summary":"Ares Capital offers an especially high forward dividend yield of 9.42%.Enterprise Products Partners has increased its distribution for 26 consecutive years.Pfizer's prospects are better than they might seem.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/20/3-ultra-high-yield-dividend-stocks-to-buy-right-no/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4599","LU1066053197.SGD","US10Y.BOND","AACT.U","BK4568","US6M.BOND","BK4007","SG9999001176.SGD","SG9999002224.SGD","LU0234572021.USD","LU0170899867.USD","LU0321505439.SGD","LU0306807586.USD","LU1894683264.USD","LU1894683348.USD","SG9999011175.SGD","LU1023059063.AUD","LU1883839398.USD","US5Y.BOND","IE00B19Z3B42.SGD","US2Y.BOND","BK4581","US30Y.BOND","SG9999001176.USD","SGXZ57979304.SGD","SG9999013999.USD","SG9999002232.USD","LU0306806265.USD","LU1066051498.USD","BDC","IE00BLSP4452.SGD","LU0456855351.SGD","PFE","LU0985481810.HKD","BK4533","BK4585","IE00BLSP4239.USD","US3Y.BOND","IE00BBT3K403.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU0225771236.USD","LU0321505868.SGD","US7Y.BOND","BK4592","US12M.BOND","LU1057294990.SGD","BK4534","LU0289739699.SGD","LU0058720904.USD"],"gpt_icon":1},{"id":"2528008268","title":"3 Magnificent Stocks to Buy That Are Near 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2528008268","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528008268?lang=en_us&edition=fundamental","pubTime":"2025-04-19 20:30","pubTimestamp":1745065800,"startTime":"0","endTime":"0","summary":"Despite a challenging market, companies with consistent profitability can emerge stronger.High-quality stocks at their 52-week lows can sometimes represent a good entry point for investors.Shares of Zoetis, Pfizer, and Nike have been volatile but remain well-positioned to rebound.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/19/3-magnificent-stocks-to-buy-that-are-near-52-week/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0708994859.HKD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU1057294990.SGD","LU2098885051.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","BK4566","LU1066053197.SGD","SG9999013999.USD","PFE","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","BK4146","LU0029864427.USD","LU0234572021.USD","BK4561","BK4534","BK4535","SG9999002232.USD","LU0868494617.USD","LU1303367103.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","BK4548","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4558","BK4585","SG9999001176.USD","NKE","SGXZ57979304.SGD","IE00B19Z3581.USD","LU0786609619.USD","BNTX","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0128525929.USD","LU0225771236.USD","LU0310800379.SGD","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2528315033","title":"Japan's Nikkei notches best week in 3 months on trade deal hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2528315033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528315033?lang=en_us&edition=fundamental","pubTime":"2025-04-18 14:50","pubTimestamp":1744959053,"startTime":"0","endTime":"0","summary":"Japan's Nikkei notches best week in 3 months on trade deal hopesUpdates with closing pricesBy Kevin Buckland. TOKYO, April 18  - Japan's Nikkei share average rose 1% on Friday to clock its best week in three months, as investors turned more hopeful that U.S. President Donald Trump would be able to broker trade deals with some of its top trading partners, including Japan.The Nikkei .N225 touched a two-week high of 34,758.97 before ending the day up 1.03% at 34,730.28, despite somewhat muted trading due to the Easter holidays in most other markets.The broader Topix .TOPX added 1.14%.The Nikkei climbed 3.41% for the week - the most since January 20 - to snap a three-week losing run.On Thursday, Trump and close ally Italian Prime Minister Giorgia Meloni expressed optimism about resolving U.S.-European Union trade tensions. Trump also signalled a potential end to tit-for-tat tariff hikes with China.A day earlier, Japan's top negotiator, economy minister Ryosei Akazawa, kicked off dialogue i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nL1N3QW032:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","LU1035775433.USD","LU0820561818.USD","LU1868836757.USD","IE0009355771.USD","LU1232071149.USD","LU1366192091.USD","LU2471134796.USD","LU1983299246.USD","LU1917777945.USD","LU2552382132.HKD","LU2237443465.HKD","LU1551013425.SGD","LU0198837287.USD","LU1069344957.HKD","LU1720051017.SGD","BK4581","LU2237443978.SGD","LU2471134523.USD","LU0122379950.USD","LU0823416689.USD","BK4599","LU2237443549.SGD","LU0466842654.USD","GB00BDT5M118.USD","IE00BJT1NW94.SGD","SG9999014914.USD","LU2750360997.AUD","SGXZ31699556.SGD","LU0672654240.SGD","LU2491050071.SGD","LU1814569148.SGD","LU0109391861.USD","BK4007","IE00BJLML261.HKD","SG9999001176.USD","LU0385154629.USD","LU0640476718.USD","LU0456855351.SGD","LU2063271972.USD","LU2471134879.HKD","LU2491050154.USD","LU1868836914.USD","LU1868837300.USD","LU0320765059.SGD","SG9999015952.SGD","SG9999017495.SGD","LU1093756168.USD","LU2750360641.GBP"],"gpt_icon":1},{"id":"2528085776","title":"Market Chatter: Eli Lilly Releases Obesity Drug Zepbound in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528085776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528085776?lang=en_us&edition=fundamental","pubTime":"2025-04-18 11:27","pubTimestamp":1744946840,"startTime":"0","endTime":"0","summary":"Eli Lilly has launched Zepbound in Japan to target visceral fat, with up to 18 million potential patients, Nikkei reported Thursday.Approved on April 11, the weekly injection activates GIP and GLP-1 hormone receptors to aid weight loss. In trials, it reduced weight by 20% on average, compared with 14% for Novo Nordisk's Wegovy, launched in February, the report said.Monthly costs can reach 45,000 yen. Access is limited to patients with obesity and related health issues, and only approved medical institutions can administer it, according to the report.Lilly and local distributor Mitsubishi Tanabe Pharma expect peak Japan sales of 31.9 billion yen, the report said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014906.USD","LU1804176565.USD","IE00BK4W5L77.USD","LU1057294990.SGD","LU1023059063.AUD","LU2237443465.HKD","SG9999015952.SGD","LU2023250504.SGD","IE0004445239.USD","LU1623119135.USD","LU1814569148.SGD","LU2360106947.USD","LU0289739699.SGD","LU2750360997.AUD","LU0058720904.USD","LU1868837300.USD","SGXZ81514606.USD","LU1093756325.SGD","LLY","LU1988902786.USD","BK4599","LU2361045086.USD","LU1232071149.USD","IE00B2B36J28.USD","LU1366192091.USD","LU1551013342.USD","LU2089984988.USD","LU0471298694.HKD","LU0689472784.USD","LU2471134952.CNY","BK4007","LU0238689110.USD","SG9999014914.USD","LU1127390331.HKD","LU0640476718.USD","LU2471134796.USD","LU2750360641.GBP","SGXZ51526630.SGD","SG9999015978.USD","LU0061475181.USD","LU0109391861.USD","SG9999013999.USD","LU0203202063.USD","LU0882574055.USD","LU2324357040.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU2063271972.USD","LU0198837287.USD","SG9999015945.SGD"],"gpt_icon":1},{"id":"2528334708","title":"Chugai Highlights Eli Lilly’s Promising Phase 3 Results for Orforglipron","url":"https://stock-news.laohu8.com/highlight/detail?id=2528334708","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528334708?lang=en_us&edition=fundamental","pubTime":"2025-04-18 07:52","pubTimestamp":1744933930,"startTime":"0","endTime":"0","summary":"An announcement from Chugai Pharmaceutical Co ( ($JP:4519) ) is now available. Chugai Pharmaceutical Co., Ltd. announced that Eli Lilly’s oral GLP-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chugai-highlights-eli-lillys-promising-phase-3-results-for-orforglipron?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chugai-highlights-eli-lillys-promising-phase-3-results-for-orforglipron?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","LU2552382132.HKD","SG9999018865.SGD","BK4585","LU2361045086.USD","SGXZ81514606.USD","LU0882574139.USD","LU0006306889.USD","BK4516","LU0689472784.USD","LU1720051108.HKD","LU1267930730.SGD","SGXZ99366536.SGD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1035775433.USD","LU1061106388.HKD","LU0708995401.HKD","LLY","LU1989771016.USD","LU2211815571.USD","IE0002141913.USD","LU0122379950.USD","LU1551013342.USD","LU1623119135.USD","LU2324357040.USD","SG9999018857.SGD","LU1868837300.USD","LU0289739699.SGD","LU0256863811.USD","BK4599","LU1917777945.USD","LU2264538146.SGD","LU2237443895.HKD","LU0456855351.SGD","LU1868836591.USD","LU2237443549.SGD","SG9999013999.USD","SGXZ31699556.SGD","LU0094547139.USD","LU2237438978.USD","BK4534","SG9999014880.SGD","LU2360106947.USD","LU1057294990.SGD","LU0354030438.USD","LU1974910355.USD","SG9999014914.USD"],"gpt_icon":0},{"id":"2528703960","title":"Short Week Finishes with Netflix Q1 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2528703960","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528703960?lang=en_us&edition=fundamental","pubTime":"2025-04-18 06:18","pubTimestamp":1744928280,"startTime":"0","endTime":"0","summary":"Netflix NFLX shares are surging ahead more than +4% in late trading following its better-than-expected earnings results and guidance in Q1: earnings of $6.61 per share took out the Zacks consensus by nearly a full dollar  on revenues that were a smidge light of estimates: $10.543 billion versus the $10.55 billion analysts were looking for.Next-quarter guidance is now moved up to $7.03 per share versus $6.22 previously. Operating Margins rose +5% month over month to +31.7% — pretty impressive. But Netflix no longer reports detailed subscriber numbers in its quarterly earning report, nor does it trace subscriber growth internationally. It has a lot of subscribers, however — this is very clear.In fact, if we are to enter a recession, Netflix may be a good place to hide out, as families begin to pinch pennies and attempt to keep their entertainment costs under control. Shares are up +4.5% in late trading on this news, adding to the company’s +9% performance year to date.What to Expect from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/short-week-finishes-netflix-q1-221800522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0130103400.USD","AMGN","3NVD.UK","NVDS.UK","LU0097036916.USD","IE00BDRTCR15.USD","BK4008","LU0426417589.USD","NVDU","HK0000320223.HKD","LU2265009873.SGD","LU0648000940.SGD","CMG","LU0985320562.USD","LU2237957811.SGD","LU2764262908.HKD","BK4559","TSYW.SI","USJW.SI","IE00BJTD4N35.SGD","2NVD.UK","LU1815336760.USD","PG","BK4612","SNVD.UK","NVD2.UK","LU0149725797.USD","NVD3.UK","BK4599","NFLX","NVDS","IE00B19Z8W00.USD","UNH","LU0795875086.SGD","NVDD","NVDY","NVIW.SI","IE00BFTCPJ56.SGD","LU0345769128.USD"],"gpt_icon":1},{"id":"2528774147","title":"Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528774147","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528774147?lang=en_us&edition=fundamental","pubTime":"2025-04-18 06:00","pubTimestamp":1744927213,"startTime":"0","endTime":"0","summary":"In the latest trading session, Amgen  closed at $277.29, marking a -1.89% move from the previous day. This change lagged the S&P 500's 0.13% gain on the day. At the same time, the Dow lost 1.33%, and the tech-heavy Nasdaq lost 0.13%.Shares of the world's largest biotech drugmaker have depreciated by 10.49% over the course of the past month, underperforming the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%.Investors will be eagerly watching for the performance of Amgen in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on May 1, 2025. The company is forecasted to report an EPS of $4.14, showcasing a 4.55% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $7.94 billion, reflecting a 6.6% rise from the equivalent quarter last year.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Ran","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-amgn-stock-sinks-market-220013239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4599","LU0122379950.USD","AMGN","BK4585","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1061106388.HKD","LU1571399168.USD","IE00B2B36J28.USD","BK4566","LU1023059063.AUD","BK4588","LU2468319806.SGD","LU0868494617.USD","LU2089984988.USD","SG9999001440.SGD","LU0109394709.USD","BK4581","IE0002141913.USD","BK4533","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0320765992.SGD","LU2112291526.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4534","LU1983299246.USD","LU2242652126.USD","IE0009355771.USD","LU0289739699.SGD","BK4139","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2528756777","title":"Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528756777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528756777?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:50","pubTimestamp":1744926615,"startTime":"0","endTime":"0","summary":"Viking Therapeutics, Inc.  ended the recent trading session at $23.94, demonstrating a +1.44% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.13%. Meanwhile, the Dow lost 1.33%, and the Nasdaq, a tech-heavy index, lost 0.13%.The company's stock has dropped by 21.52% in the past month, falling short of the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%.Market participants will be closely following the financial results of Viking Therapeutics, Inc. in its upcoming release. The company plans to announce its earnings on April 23, 2025. The company's upcoming EPS is projected at -$0.34, signifying a 30.77% drop compared to the same quarter of the previous year.It is also important to note the recent changes to analyst estimates for Viking Therapeutics, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-beats-215015260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","ISBC","BK4585","BK4211","VKTX","BK4588","BK4139"],"gpt_icon":0},{"id":"2528977577","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2528977577","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528977577?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:40","pubTimestamp":1744922420,"startTime":"0","endTime":"0","summary":"UPDATE 1-Asia Morning Call-Global MarketsApril 18 (Reuters) - Stock Marketsclosing level)Net ChngStock MarketsNet ChngS&P/ASX 200**7819.160.2NZX 50**12118.9951.07DJIA39142.23-527.16NIKKEI**34377.6457.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV1V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298694.HKD","LU0097036916.USD","LU2552382132.HKD","LU1551013342.USD","LU2471134879.HKD","LU1974910355.USD","IE0002141913.USD","LU2491050154.USD","LU2089984988.USD","LU1057294990.SGD","LU2491050071.SGD","GIC","BK4599","SGXZ31699556.SGD","LU2237443465.HKD","LU1868837136.USD","LU1093756325.SGD","LU0079474960.USD","LU0320765059.SGD","LU0820561909.HKD","SG9999015952.SGD","IE00BK4W5L77.USD","LU0061475181.USD","LU2237443382.USD","LU1232071149.USD","LU0203201768.USD","LU1814569148.SGD","LU2063271972.USD","SG9999014880.SGD","SG9999017495.SGD","LU0203202063.USD","LU0354030511.USD","LU0471298777.SGD","LU0672654240.SGD","GB00BDT5M118.USD","LU0238689110.USD","LU0820561818.USD","IE00BK4W5M84.HKD","LU2237443978.SGD","LU1366192091.USD","LU1551013425.SGD","LU1983299246.USD","LU0096364046.USD","LU0256863811.USD","LU1720051017.SGD","LU0109391861.USD","LU0114720955.EUR","LU0456855351.SGD","LU0385154629.USD"],"gpt_icon":1},{"id":"2528477921","title":"Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528477921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528477921?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:15","pubTimestamp":1744920900,"startTime":"0","endTime":"0","summary":"NEW YORK, April 17, 2025  -- Royalty Pharma plc  today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:30 a.m. Eastern Time that day.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-announce-first-quarter-201500684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1894683264.USD","IE00B19Z3B42.SGD","BK4599","BK4592","BK4581","LU1023059063.AUD","LU1894683348.USD","SG9999013999.USD","LU0058720904.USD","BK4007","LU0170899867.USD","LU1883839398.USD","SG9999002224.SGD","BK4585","IE00BBT3K403.USD","LU0868494617.USD","LU0122379950.USD","BK4588","LU0234572021.USD","IE00BLSP4239.USD","LU0321505439.SGD","SG9999001176.SGD","SG9999011175.SGD","IE0002270589.USD","BK4534","BK4533","LU0456855351.SGD","BK4568","LU0321505868.SGD","SG9999002232.USD","IE00B19Z3581.USD","LU0985481810.HKD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999001176.USD","LU0306806265.USD","LU0225771236.USD","LU1066053197.SGD","LU1057294990.SGD","RPRX","BK4550","LU0306807586.USD","LU1066051498.USD","LU0225284248.USD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2528778005","title":"Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778005","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778005?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:01","pubTimestamp":1744920060,"startTime":"0","endTime":"0","summary":"NAARDEN, the Netherlands and MIAMI, April 17, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Adele Gulfo as an independent director to its Board of Directors. Ms. Gulfo is an established pharmaceutical leader with over three decades of experience in the healthcare industry, distinguished by her expertise in global strategy, operations leadership, and the commercialization of multiple blockbuster medicines including LIPITOR and CRESTOR .","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4588","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","BK4022","NAMS","IE00BBT3K403.USD","BK4599","LU1066051498.USD","LU1066053197.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","BK4007","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","LU0456855351.SGD","LU1883839398.USD","R","IE00B19Z3B42.SGD","BK4139","BK4533","SG9999003800.SGD","LU1894683348.USD","LU0122379950.USD","LU0058720904.USD","LU1894683264.USD","SG9999011175.SGD","LU1057294990.SGD","BK4232","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0289739699.SGD","LU0985481810.HKD","LU0321505868.SGD","BK4592","BK4585","LU1023059063.AUD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2528722823","title":"Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2528722823","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528722823?lang=en_us&edition=fundamental","pubTime":"2025-04-18 01:25","pubTimestamp":1744910734,"startTime":"0","endTime":"0","summary":"Pfizer recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at increased risk. Despite this positive development, Pfizer's shares saw a 2% decline over the past week. This move is in line with broader market trends, as the market dropped by 3% during the same period. The company's decision to halt development of Danuglipron, an oral weight loss drug, due to safety concerns, may have also added weight to the downward pressure on its shares, amid wider concerns impacting the healthcare sector and investor sentiment surrounding safety in drug development.Pfizer has 3 possible red flags  we think you should know about.The recent CDC recommendation for Pfizer's RSV vaccine, ABRYSVO, is a promising development that could positively impact the company's revenue and earnings forecasts; however, the decision to halt development of the Danuglipron weight loss drug amplifies concerns over safety in drug development. This mix of news, coupled with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-gets-cdc-172534992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","NYSE","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","CDC","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","LU0868494617.USD","BK4533","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2528268817","title":"Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2528268817","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528268817?lang=en_us&edition=fundamental","pubTime":"2025-04-18 00:46","pubTimestamp":1744908360,"startTime":"0","endTime":"0","summary":"Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/17/eli-lilly-stock-soaring-novo-nordisk-viking-slide/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0689472784.USD","LU2361044865.SGD","LU0354030511.USD","LU1035775433.USD","LLY","LU1267930730.SGD","LU0097036916.USD","LU0058720904.USD","LU1974910355.USD","LU0823416689.USD","LU2211815571.USD","LU1093756325.SGD","LU1868837136.USD","SG9999015986.USD","VKTX","LU0417517546.SGD","LU2471134796.USD","LU0198837287.USD","LU1061106388.HKD","LU0289739699.SGD","LU1093756168.USD","LU2491050071.SGD","LU1623119135.USD","LU2461242641.AUD","BK4007","LU1868837300.USD","LU0882574055.USD","SG9999017495.SGD","LU2063271972.USD","LU1720051017.SGD","LU2471134523.USD","LU0354030438.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0061475181.USD","LU0456855351.SGD","SG9999001176.USD","LU2750360997.AUD","LU1548497426.USD","LU2471134879.HKD","BK4599","LU2112291526.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU0385154629.USD","SGXZ81514606.USD"],"gpt_icon":1},{"id":"2528889728","title":"Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=2528889728","media":"CoinMarketCap","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528889728?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:54","pubTimestamp":1744905265,"startTime":"0","endTime":"0","summary":"Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult ourwebsite policyprior to making financial decisions.In a significant advancement for diabetes and weight-loss treatment, Eli Lilly  has unveiled promising trial results for its new oral medication, orforglipron. The experimental pill has shown similar efficacy to the popular injectable drug Ozempic, marking a pivotal moment in the pharmaceutical industry. Following the announcement, Eli Lilly’s shares experienced a notable surge, underscoring the potential impact on the global obesity treatment market. With plans to seek regulatory approval by the end of the year, Eli Lilly is poised to become a dominant player in this lucrative sector. The safety profile of orforglipron aligns with existing GLP-1 class drugs, offering manageable side effects and further solidifying its competitive edge as Pfizer steps back from its rival drug development.Eli Lilly Makes Breakthrough as Global Obesi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/680124385049cc7044ea6893/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["IE00BBT3K403.USD","LU1066053197.SGD","SG9999015978.USD","LU2265009873.SGD","IE0002141913.USD","LU1066051498.USD","IE00BLSP4452.SGD","SG9999015945.SGD","SGXZ31699556.SGD","SGXZ81514606.USD","BK4568","LU1868837136.USD","BK4599","LU0823416689.USD","SG9999017495.SGD","LU0321505868.SGD","LU0225771236.USD","SG9999002224.SGD","LU2237443895.HKD","LU1883839398.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","IE00BK4W5M84.HKD","IE0002270589.USD","LU0256863811.USD","IE0009355771.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU1057294990.SGD","LU0471298694.HKD","BK4588","LU0868494617.USD","LU2112291526.USD","LU1548497426.USD","SG9999014914.USD","LU0122379950.USD","IE0004445239.USD","LLY","SGXZ57979304.SGD","LU0456855351.SGD","LU0466842654.USD","LU2361044865.SGD","LU0058720904.USD","BK4516","LU0289739699.SGD","LU0097036916.USD","LU0471298777.SGD","LU0106261372.USD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2528364742","title":"European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2528364742","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528364742?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:05","pubTimestamp":1744902319,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were modestly higher late Thursday morning, rising 0.31% to 1,331.70 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and telecommunications company Ericsson , which rose 2.7% and 2.3% respectively. They were followed by biopharmaceutical company Cellectis  and telecommunications operator Telefonica , which were up 2.1% and 2% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and furniture maker Natuzzi , which lost 8.3% and 3.2% respectively. They were followed by 3D printer company Materialise  and biopharmaceutical company Genfit , which dropped 2.4% and 1.8% respectively.From the UK and Ireland, the gainers were led by insurance company Prudential  and biotech firm Autolus Therapeutics , which increased 3.7% and 3.3% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group  a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4515","BK4201","BK4532","LU0162691827.USD","NTZ","BK4082","LU1162221912.USD","BK4139","GNFT","NVO","BK4546","LU1093756325.SGD","IE00BKVL7J92.USD","MREO","LU1829250122.USD","BDRX","BK4115","LU1093756168.USD","AKTX","BK4007","BK4117","AFG","LU0072461881.USD","BK4505","NCNA","BK4107","LU0154236417.USD","NVO.AU","BK4585","TEF","LU0320765646.SGD","CLLS","AMRN","BK4554","BK4591","BP","BK4162","BK4020","AUTL","EDAP","ERIC","BK4023","BK4599","PUK","BK4095","MTLS","IE00BZ1G4Q59.USD","BK7104","BK4588"],"gpt_icon":1},{"id":"2528459407","title":"Early notable gainers among liquid option names on April 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2528459407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528459407?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:55","pubTimestamp":1744898114,"startTime":"0","endTime":"0","summary":"Notable gainers among liquid option names this morning include Eli Lilly (LLY) $852.95 +118.05, Fidelity National Information Services (FIS) $73.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-april-17th-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-april-17th-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU1720051017.SGD","IE00B1BXHZ80.USD","IE0009355771.USD","LU0006061336.USD","LU1917777945.USD","LU1814569148.SGD","FIS","LU1861217088.USD","LU1720051108.HKD","LU0640476718.USD","LU0354030511.USD","LU2324357040.USD","LU2360107671.USD","GB00BDT5M118.USD","BK4516","IE00BK4W5L77.USD","LLY","LU1064131342.USD","LU1280957306.USD","BK4007","LU0128525689.USD","LU1868837136.USD","LU2237443895.HKD","LU1868836757.USD","LU0672654240.SGD","LU0094547139.USD","LU2360106947.USD","LU2468319806.SGD","LU2264538146.SGD","LU0238689110.USD","LU2750360641.GBP","LU0820561909.HKD","LU1712237335.SGD","LU0354030438.USD","LU2471134879.HKD","BK4599","LU1366192091.USD","LU2471134796.USD","LU0795875169.SGD","IE00BJT1NW94.SGD","LU2552382058.USD","SG9999014914.USD","LU0949170772.SGD","LU0061475181.USD","LU1023059063.AUD","SG9999017495.SGD","LU0943347566.SGD","LU0122379950.USD","LU0471298777.SGD"],"gpt_icon":0},{"id":"2528674596","title":"Eli Lilly rises 13.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528674596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528674596?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:50","pubTimestamp":1744897843,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) is up 13.0%, or $95.27 to $830.17. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-rises-13-0?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-rises-13-0?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1064131342.USD","LU1023059063.AUD","LU1720051108.HKD","LU1366192091.USD","LU1868836757.USD","BK4599","IE00BJT1NW94.SGD","LU0471298777.SGD","LU1917777945.USD","LU1712237335.SGD","LU0097036916.USD","LU2360106947.USD","LU2324357040.USD","LU2468319806.SGD","BK4007","LU0820561909.HKD","LU2552382058.USD","BK4516","LU0354030438.USD","LU1868837300.USD","LU2471134879.HKD","LU2237443895.HKD","LU1814569148.SGD","LU2471134796.USD","LU1280957306.USD","SG9999001176.SGD","IE00B1BXHZ80.USD","SG9999014914.USD","LU0672654240.SGD","LU1623119135.USD","LU2750360641.GBP","LU2264538146.SGD","LU0122379950.USD","LLY","LU0640476718.USD","LU0094547139.USD","LU1551013342.USD","LU0943347566.SGD","SG9999017495.SGD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0061475181.USD","LU0354030511.USD","IE0009355771.USD","LU0203201768.USD","LU1868837136.USD","LU0238689110.USD","BK4533","LU1720051017.SGD","LU1093756325.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":150,"code":"91000000","status":"200"}]}}